DNA Virus Infections  >>  irinotecan  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
irinotecan / Generic mfg.
NCT00004922: Irinotecan in Treating Patients With Advanced Neuroendocrine Tumors

Completed
2
US
irinotecan hydrochloride
Memorial Sloan Kettering Cancer Center, National Cancer Institute (NCI)
Carcinoma of Unknown Primary, Neuroendocrine Carcinoma, Neuroendocrine Carcinoma of the Skin
06/02
06/02

Download Options